XML 63 R46.htm IDEA: XBRL DOCUMENT v3.24.0.1
Investments (Tables)
12 Months Ended
Dec. 31, 2023
Equity Method Investments and Joint Ventures [Abstract]  
Equity Method Investments and Investments Carried Under Measurement Alternative
Equity Method Investments and Investments Carried Under the Measurement Alternative
(in thousands)
Percent Ownership1
December 31, 2023December 31, 2022
Advanced Markets Holdings25%$4,481 $5,090 
China Credit BGC Money Broking Company Limited33%21,277 21,104 
Freedom International Brokerage45%9,507 9,659 
Other2,857 2,530 
Equity method investments$38,122 $38,383 
Investments carried under measurement alternative192 192 
Total equity method and investments carried under measurement alternative$38,314 $38,575 
_______________________________________
1Represents the Company’s voting interest in the equity method investment as of December 31, 2023 and 2022.
Summary of Financial Information for Company's Equity Method Investments
Summarized financial information for the Company’s equity method investments is as follows (in thousands):
Year Ended December 31,
202320222021
Statements of operations:
Total revenues$111,242 $125,405 $108,458 
Total expenses84,216 88,050 82,581 
   Income before income taxes$27,026 $37,355 $25,877 
December 31,
20232022
Statements of financial condition:
Cash and cash equivalents$79,440 $82,725 
Fixed assets, net1,900 1,848 
Other assets51,336 54,744 
Total assets$132,676 $139,317 
Payables to related parties— — 
Other liabilities81,898 78,740 
Total partners’ capital50,779 60,577 
Total liabilities and partners’ capital$132,677 $139,317 
Investments in Variable Interest Entities
The following table sets forth the Company’s investment in its unconsolidated VIEs and the maximum exposure to loss with respect to such entities (in thousands).
December 31, 2023December 31, 2022
InvestmentMaximum
Exposure to Loss
InvestmentMaximum
Exposure to Loss
Variable interest entities1
$2,857 $2,857 $2,530 $2,959 
__________________
1The Company’s maximum exposure to loss with respect to its unconsolidated VIEs includes the sum of its equity investments. The Company has entered into a subordinated loan agreement with Aqua, whereby the Company agreed to lend the principal sum of $1.0 million. The Company did not recognize any interest income on the subordinated loan subsequent to being designated as a non-accrual loan in November 2022. As of December 31, 2022, the Company had written off $0.6 million of the subordinated loan, which was recorded as part of “Other expenses” on the Companys Consolidated Statements of Operations. As of December 31, 2023, the Company had received cash payment fully satisfying the remaining subordinated loan receivable of $0.4 million.